SEC Form 4 · accession 0001638599-17-000506
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Oconnor
Director
Period of report
May 25, 2017
Accepted (ET)
May 26, 2017 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 25, 2017 | M | 5,000 | $14.47 | A | 58,275 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $14.47 | May 25, 2017 | M | 5,000 | D | — | Jun 4, 2017 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1This option is currently exercisable.